Protagonist Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $4,712 | $5,546 | $28,321 | $170,638 |
Gross Profit | 4,712 | 5,546 | 28,321 | 170,638 |
EBITDA | -38,978 | -41,737 | -19,071 | 127,316 |
EBIT | -39,339 | -42,041 | -19,310 | 126,780 |
Net Income | -39,339 | -34,771 | -11,655 | 131,674 |
Net Change In Cash | 4,712 | 5,546 | 28,321 | 170,638 |
Free Cash Flow | -2,025 | -29,593 | 124,818 | -29,488 |
Cash | 113,713 | 168,543 | 139,653 | 97,249 |
Basic Shares | 63,772 | 63,511 | 62,964 | 66,406 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $434,433 | $60,000 | $26,581 | $27,357 |
Gross Profit | 434,433 | 60,000 | 26,581 | 27,357 |
EBITDA | 253,669 | -90,340 | -128,004 | -123,070 |
EBIT | 252,843 | -93,652 | -131,373 | -125,845 |
Net Income | 275,188 | -78,955 | -123,413 | -125,551 |
Net Change In Cash | 434,433 | 60,000 | 26,581 | 27,357 |
Cost of Revenue | 2,169 | 6,198 | ||
Free Cash Flow | 182,797 | -70,845 | -108,932 | -108,966 |
Cash | 97,249 | 186,727 | 125,744 | 123,665 |
Basic Shares | 65,078 | 56,763 | 49,042 | 46,322 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.62 |
2025-06-30 | -$0.55 |
2025-03-31 | -$0.19 |
2024-12-31 | $1.98 |
